HomeV7B • FRA
add
Assembly Biosciences Inc
Previous close
€15.30
Day range
€15.25 - €15.25
Year range
€10.14 - €17.95
Market cap
107.75M USD
Avg Volume
700.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 8.53M | — |
Operating expense | 4.48M | -9.83% |
Net income | -11.15M | 34.00% |
Net profit margin | -130.69 | — |
Earnings per share | -1.98 | 48.44% |
EBITDA | -12.17M | 29.90% |
Effective tax rate | -3.78% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 109.22M | 82.55% |
Total assets | 115.32M | 73.22% |
Total liabilities | 80.64M | 593.51% |
Total equity | 34.68M | — |
Shares outstanding | 6.35M | — |
Price to book | 2.80 | — |
Return on assets | -25.94% | — |
Return on capital | -85.98% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -11.15M | 34.00% |
Cash from operations | -17.10M | -25.49% |
Cash from investing | 5.11M | 161.05% |
Cash from financing | 12.45M | 9,194.03% |
Net change in cash | 459.00K | 102.10% |
Free cash flow | -3.92M | 47.52% |
About
Founded
2005
Headquarters
Website
Employees
65